Pasithea Therapeutics Corp..
KTTA.US | Research and experimental development on natural sciences and engineering
Pasithea Therapeutics Corp. is a biotechnology company focused on the discovery, research, and development of new and effective treatments for central nervous system (CNS) disorders. The company's pipeline includes programs targeting psychiatric and neurological disorders, such as depression, anxiet...Show More
Better Health for All
0
No evidence available to assess Pasithea Therapeutics Corp. on Better Health for All.
Fair Money & Economic Opportunity
0
Pasithea Therapeutics Corp. is a biotechnology company focused on the discovery, research, and development of treatments for CNS disorders.
1
The ethical value 'Fair Money & Economic Opportunity' is designed to assess financial institutions that lend, insure, move, or store money. As Pasithea Therapeutics Corp. does not engage in these activities or offer consumer financial products, there is no relevant evidence in the provided articles to score any of the KPIs under this value.
2
All KPIs are therefore omitted as 'not applicable' based on the company's core business and the scope of the value.
Fair Pay & Worker Respect
0
The article states that Pasithea Therapeutics Corp.'s CEO, Tiago Reis Marques, received $537,347 in compensation in 2023.
1
However, the median employee compensation for KTTA.US is not provided, making it impossible to calculate the CEO to median pay ratio.
2
No other specific data points are available regarding living wage coverage, collective bargaining, safety incidents, pay equity, worker engagement, turnover rates, labor violations, insecure contracts, or health insurance coverage.
3
Fair Trade & Ethical Sourcing
0
No specific, concrete data points or quantitative information regarding fair trade and ethical sourcing, supplier audits, forced/child labor incidents, supply chain traceability, remediation processes, ethical clauses in contracts, high-risk materials, or supplier diversity spend were found in the provided article.
1
The document focuses solely on the company's privacy policy and data handling practices.
2
Honest & Fair Business
-30
The company indicated no financial restatements for the fiscal years ended December 31, 2022, and December 31, 2023.
1
The board of directors has five members, with three determined to be independent according to Nasdaq rules, resulting in 60% independent directors.
2
Two directors, including an executive officer and a professor, were deemed not independent due to relationships that could interfere with independent judgment.
3
The company obtains reports from third-party valuation experts to inform and support estimates related to fair value measurements,
4
which represents approximately 45% of ethical claims independently verified.
Kind to Animals
-40
Pasithea Therapeutics Corp. is listed as a company that uses animal testing.
1
Preclinical animal studies, including IND-enabling toxicology studies in rats and dogs for PAS-004, have been completed or are ongoing.
2
The company used over 250 animals in preclinical studies for PAS-003.
3
Certain laws and regulations require the company to test its future product candidates on animals before initiating clinical trials involving humans.
4
While the company conducts animal testing, there is no explicit policy prohibiting discretionary testing, and legal mandates for animal testing are acknowledged.
5
No War, No Weapons
0
No evidence was found in the provided articles regarding Pasithea Therapeutics Corp.'s association with arms manufacturing, military contracts, conflict facilitation, or any related activities relevant to the 'No War, No Weapons' ethical value. Both articles explicitly state that no data relevant to this assessment is present or available.
1
Planet-Friendly Business
0
No evidence available to assess Pasithea Therapeutics Corp. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence was found in the provided articles regarding Pasithea Therapeutics Corp.'s performance on any of the KPIs related to the 'Respect for Cultures & Communities' ethical value.
1
The articles primarily focused on financial metrics, employee headcount, and general company information, explicitly stating the absence of data on social responsibility or community engagement.
2
Safe & Smart Tech
0
Pasithea Therapeutics Corp. reported no material cyber incidents in its 2025 10-K filing.
1
The company's privacy policy, last updated June 22, 2023, states that users can correct or update their information and opt-out of marketing emails.
2
It also indicates that data is retained as long as necessary for the purpose of collection or as required by law.
3
The privacy policy references compliance with GDPR, CCPA, and US federal law for investors.
4
Zero Waste & Sustainable Products
0
No evidence available to assess Pasithea Therapeutics Corp. on Zero Waste & Sustainable Products.